Division of Endocrinology and Metabolism, Department of Internal Medicine, Inha University College of Medicine, Incheon, Republic of Korea.
Huh's Diabetes Center and the 21st Century Diabetes and Vascular Research Institute, Seoul, Republic of Korea.
Sci Rep. 2022 Jun 7;12(1):9384. doi: 10.1038/s41598-022-13084-6.
This study aimed to determine whether the patterns of diabetic complications differed when patients with type 2 diabetes mellitus (T2DM) were simply classified according to insulin sensitivity and beta-cell function. This observational study included 8861 patients with T2DM who underwent concurrent testing for fasting glucose, fasting insulin, and one or more diabetic complications. We categorized the patients into four groups according to insulin sensitivity and beta-cell function. Compared with the reference group (mild insulin resistance and beta-cell dysfunction), the "severe beta-cell dysfunction" group had lower odds of chronic kidney disease [adjusted odds ratios (aOR) 0.611]. The "severe insulin resistance" group had higher odds of carotid artery plaque presence (aOR 1.238). The "severe insulin resistance and beta-cell dysfunction" group had significantly higher odds of large fiber neuropathy (aOR 1.397, all p < 0.05). After a median of five years of follow-up, this group distinction did not lead to a difference in risk of new diabetic retinopathy or chronic kidney disease. In addition, there was no significant difference among the groups in plaque progression risk over 8-10 years in the longitudinal follow-up analysis. The patterns of complications differ when patients with T2DM are classified according to insulin resistance and beta-cell dysfunction. However, there were no differences in the risk of developing new complications.
本研究旨在确定当 2 型糖尿病(T2DM)患者仅根据胰岛素敏感性和β细胞功能进行分类时,糖尿病并发症的模式是否存在差异。这项观察性研究纳入了 8861 名接受空腹血糖、空腹胰岛素以及一种或多种糖尿病并发症同时检测的 T2DM 患者。我们根据胰岛素敏感性和β细胞功能将患者分为四组。与参考组(轻度胰岛素抵抗和β细胞功能障碍)相比,“严重β细胞功能障碍”组发生慢性肾脏病的几率较低[校正比值比(aOR)0.611]。“严重胰岛素抵抗”组发生颈动脉斑块的几率较高[aOR 1.238]。“严重胰岛素抵抗和β细胞功能障碍”组发生大纤维神经病的几率明显较高[aOR 1.397,均 p<0.05]。在中位随访 5 年后,这种分组差异并未导致新发糖尿病视网膜病变或慢性肾脏病的风险出现差异。此外,在纵向随访分析中,8-10 年内斑块进展风险在各组之间也没有显著差异。根据胰岛素抵抗和β细胞功能对 T2DM 患者进行分类时,并发症的模式存在差异。然而,新发并发症的风险并无差异。